ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IGMS IGM Biosciences Inc

10.07
0.64 (6.79%)
After Hours
Last Updated: 16:55:51
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
IGM Biosciences Inc IGMS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.64 6.79% 10.07 16:55:51
Open Price Low Price High Price Close Price Previous Close
9.73 9.72 10.19 10.07 9.43
more quote information »

Recent News

Date Time Source Heading
4/17/202407:30GLOBEIGM Biosciences Announces Refocusing of Sanofi Collaboration
4/10/202406:00GLOBEIGM Biosciences to Present at the Stifel 2024 Virtual..
3/07/202415:27EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/07/202415:10EDGAR2Form 8-K - Current report
3/07/202415:10GLOBEIGM Biosciences Announces Fourth Quarter and Full Year 2023..
3/05/202418:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202406:00GLOBEIGM Biosciences to Present at the Guggenheim Healthcare..
1/08/202408:00EDGAR2Form 8-K - Current report
1/03/202419:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202406:00GLOBEIGM Biosciences to Present at the 42nd Annual J.P. Morgan..
12/15/202318:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202318:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202318:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202316:36EDGAR2Form 144 - Report of proposed sale of securities
12/13/202316:33EDGAR2Form 144 - Report of proposed sale of securities
12/13/202316:30EDGAR2Form 144 - Report of proposed sale of securities
12/13/202316:27EDGAR2Form 144 - Report of proposed sale of securities
12/08/202315:05EDGAR2Form 8-K - Current report
12/05/202315:01GLOBEIGM Biosciences Announces Strategic Pipeline Prioritization..
12/01/202318:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202304:32PRNUSBulletin from Extraordinary General Meeting in Medivir AB..
11/29/202319:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/29/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/27/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/21/202301:48PRNUSMedivir to present at the Erik Penser Bank Company Event
11/13/202316:08EDGAR2Form S-3 - Registration statement under Securities Act of..
11/13/202315:10EDGAR2Form 8-K - Current report
11/13/202315:10GLOBEIGM Biosciences Announces Third Quarter 2023 Financial..
11/13/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202306:00GLOBEIGM Biosciences to Present at Two Upcoming Investor..
10/05/202318:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202318:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/05/202306:29PRNUSFostrox + Lenvima continues to show promising tumor control..
10/03/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202318:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202318:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202318:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202315:14EDGAR2Form 8-K - Current report
10/03/202315:05GLOBEIGM Biosciences Announces Retirement of Chairman Michael..
10/02/202315:27EDGAR2Form 144 - Report of proposed sale of securities
9/06/202306:00GLOBEIGM Biosciences to Present at the Morgan Stanley 21st Annual..
8/03/202315:13EDGAR2Form 8-K - Current report
8/03/202315:10GLOBEIGM Biosciences Announces Second Quarter 2023 Financial..
8/03/202315:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/19/202315:13EDGAR2Form SC 13D/A - General statement of acquisition of..

Your Recent History

Delayed Upgrade Clock